US67113Y1082
© Globe Newswire
23.01.2026
NUWE
LISTED
NASDAQ
Nuwellis Announces Changes to Board of Directors
News Preview
MINNEAPOLIS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced the appointment of Katharyn Field and Mika Grasso to its board of directors, effective January 21, 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
12.11.2025
NUWE
LISTED
NASDAQ
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
News Preview
Company delivers steady performance and achieves key milestones across critical care, pediatrics, and hospital-based outpatient therapy Company delivers steady performance and achieves key milestones across critical care, pediatrics, and hospital-based outpatient therapy...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
NUWE
LISTED
NASDAQ
Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology
News Preview
Continues momentum in pediatric innovation and platform development Continues momentum in pediatric innovation and platform development...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
23.10.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
News Preview
MINNEAPOLIS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, addressing the critical interplay between the heart and kidneys, today announced that it will release financial results for the third quarter 2025 on November 12, 2...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© Globe Newswire
18.09.2025
NUWE
LISTED
NASDAQ
Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration
News Preview
EDEN PRAIRIE, Minn., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,415,021 on September 16, 2025, based on Application No. 18/298,860....
Themefolio
Profiler
Peergroup
© Globe Newswire
17.09.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment
News Preview
Watch the “What This Means” segment here...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.08.2025
NUWE
LISTED
NASDAQ
Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
News Preview
Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from early risk assessment to targeted fluid removal...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.08.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
News Preview
Live video webcast on Thursday, August 21st at 2:40 PM ET Live video webcast on Thursday, August 21st at 2:40 PM ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.08.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
News Preview
MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced financial results for the second quarter ended June 30, 2025, and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
07.08.2025
NUWE
LISTED
NASDAQ
Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
News Preview
Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.07.2025
NUWE
LISTED
NASDAQ
Nuwellis Regains Compliance with Nasdaq Listing Requirements
News Preview
Nuwellis Regains Compliance with Nasdaq Listing Requirements...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.07.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025
News Preview
Nuwellis Announces Q2 Earnings Advisory...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
15.07.2025
NUWE
LISTED
NASDAQ
Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation
News Preview
Nuwellis Secures New U.S. Patent...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.07.2025
NUWE
LISTED
NASDAQ
Nuwellis Appoints John Erb as Chief Executive Officer
News Preview
Nuwellis Announces Appointment of John Erb as Chief Executive Officer...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.06.2025
NUWE
LISTED
NASDAQ
Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option
News Preview
MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the closing of a public offering of 2,580,667 shares of its common stock (“Common Stock”), pre-funded warrants to purchase...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.06.2025
NUWE
LISTED
NASDAQ
Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering
News Preview
MINNEAPOLIS, June 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the pricing of a public offering of 406,755 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 1...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.05.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights
News Preview
MINNEAPOLIS, May 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced financial results for the first quarter ended March 31, 2025, and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.03.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
News Preview
MINNEAPOLIS, March 11, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today reported financial results for the fourth quarter and full year ended December 31, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.02.2025
NUWE
LISTED
NASDAQ
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
News Preview
MINNEAPOLIS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today highlighted promising findings from an updated analysis of the AVOID-HF study, recently published in the Journal of the American College of Cardiology: Heart...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.02.2025
NUWE
LISTED
NASDAQ
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
News Preview
MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the fourth quarter and full year 2024 on March 11, 2025. Nuwellis will host a conference call and we...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.12.2024
NUWE
LISTED
NASDAQ
Nuwellis Regains Compliance with Nasdaq Listing Requirements
News Preview
MINNEAPOLIS, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (the “Company” or “Nuwellis”) today announced that the Company received formal written notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq's minimum bid price requirement (the “Bid Price Requirement”) set forth in Nasda...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.11.2024
NUWE
LISTED
NASDAQ
Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
News Preview
MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company focused on transforming the lives of people with fluid overload, today reported financial results for the third quarter ended September 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2024
NUWE
LISTED
NASDAQ
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
News Preview
MINNEAPOLIS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company committed to transforming the lives of people with fluid overload, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants issued by the Compa...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.11.2024
NUWE
LISTED
NASDAQ
Nuwellis Announces Preliminary Results for Third Quarter of 2024
News Preview
MINNEAPOLIS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical device company dedicated to transforming the lives of patients suffering from fluid overload, today announced certain preliminary, unaudited results for the quarter ended September 30, 2024. The company plans to report its complete results and host its earning...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2024
NUWE
LISTED
NASDAQ
Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024
News Preview
MINNEAPOLIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the third quarter of 2024 on Monday, November 11, 2024. Nuwellis will host a conference call and webcast at 9:00 AM E...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2024
NUWE
LISTED
NASDAQ
Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference
News Preview
MINNEAPOLIS, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that President and Chief Executive Officer Nestor Jaramillo will participate in ROTH Capital Partners’ third annual ROTH Healthcare Opportunities Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.08.2024
NUWE
LISTED
NASDAQ
Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
News Preview
MINNEAPOLIS, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.08.2024
NUWE
LISTED
NASDAQ
Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
News Preview
MINNEAPOLIS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial results for the second quarter ended June 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.07.2024
NUWE
LISTED
NASDAQ
Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s
News Preview
MINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, today announced that the first patient has been treated with the newly launched QUELIMMUNE™ therapy in a commercial setting at Cincinnati Children’s. QUELIMMUNE,...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.07.2024
NUWE
LISTED
NASDAQ
Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules
News Preview
MINNEAPOLIS, July 24, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.07.2024
NUWE
LISTED
NASDAQ
Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024
News Preview
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter of 2024 on Tuesday, August 13, 2024. Nuwellis will host a conference call and webcast at 9:00 AM E...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.07.2024
NUWE
LISTED
NASDAQ
Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
News Preview
MINNEAPOLIS, July 17, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, is proud to announce its first commercial sale of QUELIMMUNE™, a novel therapy developed by SeaStar Medical Holding Corporation for pediatric patients suffering f...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.07.2024
NUWE
LISTED
NASDAQ
New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference
News Preview
MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that new clinical evidence demonstrating the efficacy of its Aquadex® system will be presented at the Heart Failure Society of America...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.06.2024
NUWE
LISTED
NASDAQ
Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
News Preview
MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the recent grant of a new patent from the United States Patent and Trademark Office (USPTO) related to its groundbreaking pediatric continuous renal replacement...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.06.2024
NUWE
LISTED
NASDAQ
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
News Preview
Pilot Collaboration for Aquadex® Ultrafiltration Therapy for Adult Patients with Congestive Heart Failure is extended to August 31, 2024 Pilot Collaboration for Aquadex® Ultrafiltration Therapy for Adult Patients with Congestive Heart Failure is extended to August 31, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.05.2024
NUWE
LISTED
NASDAQ
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
News Preview
MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial results for the first quarter ended March 31, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.04.2024
NUWE
LISTED
NASDAQ
Nuwellis Announces Closing of $2.7 Million Public Offering
News Preview
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the closing of its previously announced public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
